MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
43 hedge funds and large institutions have $50.5M invested in Merrimack Pharmaceuticals, Inc. in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 17 reducing their positions, and 7 closing their positions.
Holders
43
Holders Change
-2
Holders Change %
-4.44%
% of All Funds
0.75%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
7
Reduced
17
Closed
7
Calls
$38K
Puts
$317K
Net Calls
-$279K
Net Calls Change
+$43K
Top Buyers
Top Sellers
1 |
1
Two Sigma Investments
New York
|
$397K |
2 |
2
Two Sigma Advisers
New York
|
$269K |
3 |
3
Renaissance Technologies
New York
|
$652K |
4 |
4
BlackRock
New York
|
$1.2M |
5 |
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$267K |